UKCA vs CE: How New Regulations Affected the Manufacturing of Medical Devices
Overview: UKCA vs CE Marking in Medical Device Manufacturing
Following Brexit, medical device market access divided between the United Kingdom and the European Union. The CE Mark confirms compliance with EU Medical Device Regulation (EU MDR 2017/745) across 27 EU member states, while UKCA (United Kingdom Conformity Assessed) marking governs Great Britain (England, Scotland, and Wales) under the UK Medical Devices Regulations 2002. Under current UK Medicines and Healthcare products Regulatory Agency (MHRA) guidance, valid CE-marked devices continue to be recognized in Great Britain through 30 June 2028 (for legacy MDD devices) and 30 June 2030 (for EU MDR/IVDR devices). However, non-UK manufacturers placing devices in Great Britain must appoint a UK Responsible Person (UKRP) and complete mandatory MHRA device registration.
Contact us
The Post-Brexit Regulatory Split: UKCA vs CE Marking
The departure of the United Kingdom from the European Union fundamentally changed regulatory pathways for MedTech companies. Previously, a single CE marking permitted seamless distribution across both Britain and Continental Europe. Today, manufacturers must navigate two distinct regulatory jurisdictions:
CE Marking (EU MDR / IVDR): Demonstrates self-declaration or Notified Body assessment confirming compliance with EU MDR 2017/745 or EU IVDR 2017/746 across EU member states.
UKCA Marking (UK MDR 2002): Delineates domestic conformity within Great Britain, verified via UK Approved Bodies or self-declaration where permitted.
Understanding the structural differences in a UKCA vs CE marking comparison is crucial for maintaining compliant distribution without supply chain interruption.
Key Differences Between UKCA and CE Marking Frameworks
While both frameworks share the objective of ensuring medical device safety, efficacy, and quality, their administrative and technical pathways diverge significantly:
| Regulatory Parameter | CE Marking (European Union) | UKCA Marking (Great Britain) |
| Governing Regulation | EU MDR 2017/745 & EU IVDR 2017/746 | UK Medical Devices Regulations 2002 (as amended) |
| Geographic Scope | 27 EU Member States + EEA | Great Britain (England, Scotland, Wales) |
| Conformity Assessment Body | EU Notified Bodies | UK Approved Bodies |
| Local Legal Representative | EU Authorized Representative (EC REP) | UK Responsible Person (UKRP) |
| Registration Database | EUDAMED database | MHRA DORS Portal |
| Technical Documentation | Annex II & III Technical Documentation | Technical File mapped to UK MDR 2002 |
Transitioning technical files across both regimes requires updating your foundational Quality Management System (QMS) and verifying that all technical documentation aligns with regional market expectations.
MHRA Transitional Timelines: How Long is CE Marking Accepted in Great Britain?
To protect healthcare supply chains, the UK MHRA established extended transitional arrangements allowing manufacturers to continue placing CE-marked devices on the Great Britain market.
EU MDD / AIMDD Legacy Devices: CE-marked general devices compliant with Directive 93/42/EEC remain accepted in Great Britain until 30 June 2028 (or until certificate expiry).
EU MDR & IVDR Certified Devices: Devices fully certified under EU MDR 2017/745 or EU IVDR 2017/746 remain accepted in Great Britain until 30 June 2030.
Mandatory Registration Rule: Regardless of whether a device uses a CE Mark or UKCA Mark, all medical devices placed on the market in Great Britain must be registered with the MHRA via the DORS portal.
For a deeper look into specific regional compliance dates, review our guide on UKCA marking requirements for medical devices.
How New Regulations Affected Medical Device Manufacturing Operations
The regulatory split between the EU and UK introduced operational, financial, and manufacturing complexities for global medical device producers:
1. Multi-Jurisdictional Labeling and Packaging
Packaging lines now require dual-market artwork adjustments. Devices entering both markets must display the relevant conformity marks (CE and/or UKCA), local legal representative details (EC REP and UKRP address), and specific single-use or UDI symbols.
2. Dual Technical Files & Design Verification
While initial clinical data and risk management files (ISO 14971) can be shared, technical files must be tailored. Learn more about how EU MDR affected CE marking and how design changes affect your underlying Design History File (DHF) during new product design development.
3. Requirement for a UK Responsible Person (UKRP)
Foreign medical device manufacturers without a registered physical address in the UK can no longer sell directly in Great Britain without appointing a dedicated UKRP. The UKRP assumes legal responsibility for registering devices with the MHRA, reviewing technical files, and serving as the primary liaison for vigilance reporting.
Planning dual UKCA and CE mark compliance for your product line
Schedule a regulatory roadmap consultation with Operon Strategist today.
Critical Steps for Dual UKCA and CE Compliance
To maintain uninterrupted market access in both the European Union and Great Britain, manufacturers should implement a structured transition program:
Conduct Gap Analysis: Audit legacy technical documentation against both EU MDR Annex II/III and UK MDR 2002 requirements using regulatory due diligence for medical devices.
Appoint Local Representatives: Formalize legal agreements with an EU Authorized Representative (EC REP) for Continental Europe and a UK Responsible Person (UKRP) for Great Britain.
Submit MHRA Device Registrations: Complete registration of all product families on the MHRA DORS portal.
Upgrade Quality System Standards: Ensure QMS workflows account for dual post-market surveillance (PMS) and vigilance reporting frameworks across both jurisdictions.
For actionable implementation steps, read our guide on how medical device manufacturers comply with the UKCA.
Navigating UKCA and CE Compliance with Operon Strategist
Operon Strategist provides end-to-end regulatory consulting to help global medical device manufacturers seamlessly achieve and maintain dual UKCA and CE mark compliance:
UKRP Representation & MHRA Registration: Serving as your legal UK Responsible Person and managing complete device listing on the MHRA DORS portal.
CE Marking (EU MDR / IVDR) Technical File Compilation: Structuring compliant technical documentation, clinical evaluations (CER), and risk management files for EU Notified Body audits.
UKCA Conformity Assessment Preparation: Guiding manufacturers through UK Approved Body reviews and UKCA declaration of conformity workflows.
Quality System Harmonization: Updating your ISO 13485 QMS to incorporate dual-market vigilance, post-market surveillance, and change control procedures.
Turnkey Global Market Access: Managing multi-country clearance via our Global Product Registration services.
Need a registered UK Responsible Person (UKRP)
Partner with Operon Strategist for fast-track UK market acces
FAQ's
Is CE marking still accepted in the UK for medical devices?
Yes, Great Britain accepts valid CE-marked devices under extended transition rules until 30 June 2028 for legacy MDD devices and 30 June 2030 for EU MDR/IVDR certified devices.
Can I sell a UKCA-marked medical device in the European Union?
No. The UKCA mark is recognized exclusively in Great Britain (England, Scotland, and Wales). EU member states require a valid CE mark.
What is a UK Responsible Person (UKRP)?
A UKRP is a legal entity based in the UK appointed by a non-UK manufacturer to represent them, register devices with the MHRA, and handle regulatory obligations in Great Britain.
Do I need to register my medical device with the MHRA if it already has a CE mark?
Yes. Regardless of CE certification, all medical devices placed on the market in Great Britain must be registered with the MHRA by the manufacturer or their appointed UKRP.
How does Northern Ireland handle UKCA vs CE marking?
Under the Windsor Framework/Northern Ireland Protocol, Northern Ireland aligns with EU rules, requiring CE marking or CE + UKNI marking for medical devices placed on its market.